Menu Close

Member Company Listing

Member Company Listing

Corporate Membership of the Association for Clinical Data Management was recently launched. For a fixed annual subscription the corporate membership allows you to obtain the following benefits:

  • recognition as a Member Company of the ACDM
  • unlimited number of individual ACDM members at a single location of your organisation
  • add/remove members using our online Membership Management Area
  • reduced prices for attending training courses and the Annual Conference
  • free online listing of your organisation on the ACDM website
  • free, unlimited job postings

Join as an ACDM Member Company by clicking here

Please find below a listing of some of the Company Members of the ACDM

Filter by:

CROs | IT/Software | Pharma | Biotech | RecruitmentAcademic/Healthcare ProviderMedical Food

Alvotech Alvotech

Type: Biotech

Read More

Setting a new standard in biosimilars

Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high-quality biosimilar medicines.

Who we are

We are specialists in biopharmaceutical product creation, all along the value chain from cell line development to commercial manufacturing. Our common goal is to be a global leader in the biosimilar space and to deliver high quality cost competitive products to patients worldwide. We come from all around the world, bringing literally thousands of years of combined knowledge and expertise to our mission.

Fully in-house R&D and manufacturing provide:

Cutting-edge in-house R&D capabilities, from cell line, process and product development through process scale-up and manufacturing are completed by a fully integrated clinical and regulatory function, allowing a smooth transition from development through global launch and commercial manufacturing.

State-of-the-art facility for drug substance and drug product manufacturing of biologics, complimented by QC laboratories.

Robust manufacturing processes such as single use-technology, reducing the need to clean and sterilize equipment and allowing flexibility and multiproduct manufacturing.

What we do

Our vision as a company is to build a leading global biopharmaceutical company, while focusing on the development and commercialization of biosimilar medicines for the treatment of severe and chronic conditions, that improves the quality of life for patients around the world.

Web: http://www.alvotech.com

Galapagos Galapagos

Type: Biotech

Read More

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people’s lives.

Web: http://www.glpg.com

Nutricia Research Nutricia Research

Type: Biotech

Read More

At Nutricia Research we believe that every consumer and patient deserves optimal nutritional support. We use life science, food science and technology, together with the passion, drive and expertise of over 900 employees, to pioneer nutritional solutions for those with special nutritional needs

Web: https://www.nutriciaresearch.com

Roche Roche

Type: Biotech

Read More

Globally, Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life, safety and survival of patients. Twenty-eight medicines developed by Roche are included in the WHO Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. Roche in the UK employs over 2,000 people in pharmaceuticals and diagnostics

Web: https://www.roche.co.uk

SOTIO SOTIO

Type: Biotech

Read More

SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group. For more information, please visit the company’s website at www.sotio.com.

Web: http://www.sotio.com